Literature DB >> 21631354

The role of nuclear factor κB in the interferon response.

Lawrence M Pfeffer1.   

Abstract

The nuclear factor κB (NF-κB) transcription factor regulates the expression of genes involved in cell survival and immune responses. We have identified a novel interferon (IFN)-activated signaling pathway that leads to NF-κB activation and demonstrate that a subset of IFN-stimulated genes and microRNAs that play key roles in cellular response to IFN is regulated by NF-κB. This review focuses on the IFN-induced NF-κB activation pathway and the role of NF-κB in the expression of IFN-induced coding and noncoding genes, antiviral activity and apoptosis, and the therapeutic application of IFN in cancer and infectious disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21631354      PMCID: PMC3128784          DOI: 10.1089/jir.2011.0028

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  44 in total

1.  Interferon alpha activates NF-kappaB in JAK1-deficient cells through a TYK2-dependent pathway.

Authors:  Chuan He Yang; Aruna Murti; William J Valentine; Ziyun Du; Lawrence M Pfeffer
Journal:  J Biol Chem       Date:  2005-05-09       Impact factor: 5.157

Review 2.  IkappaB-NF-kappaB structures: at the interface of inflammation control.

Authors:  P A Baeuerle
Journal:  Cell       Date:  1998-12-11       Impact factor: 41.582

3.  STAT3 complements defects in an interferon-resistant cell line: evidence for an essential role for STAT3 in interferon signaling and biological activities.

Authors:  C H Yang; A Murti; L M Pfeffer
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

Review 4.  Inflammation-associated cancer: NF-kappaB is the lynchpin.

Authors:  Qiutang Li; Sebo Withoff; Inder M Verma
Journal:  Trends Immunol       Date:  2005-06       Impact factor: 16.687

5.  STAT3 as an adapter to couple phosphatidylinositol 3-kinase to the IFNAR1 chain of the type I interferon receptor.

Authors:  L M Pfeffer; J E Mullersman; S R Pfeffer; A Murti; W Shi; C H Yang
Journal:  Science       Date:  1997-05-30       Impact factor: 47.728

6.  Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs.

Authors:  Lee P Lim; Nelson C Lau; Philip Garrett-Engele; Andrew Grimson; Janell M Schelter; John Castle; David P Bartel; Peter S Linsley; Jason M Johnson
Journal:  Nature       Date:  2005-01-30       Impact factor: 49.962

7.  Suppression of TNF-alpha-induced apoptosis by NF-kappaB.

Authors:  D J Van Antwerp; S J Martin; T Kafri; D R Green; I M Verma
Journal:  Science       Date:  1996-11-01       Impact factor: 47.728

8.  TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB.

Authors:  C Y Wang; M W Mayo; A S Baldwin
Journal:  Science       Date:  1996-11-01       Impact factor: 47.728

9.  MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells.

Authors:  Jennifer A Chan; Anna M Krichevsky; Kenneth S Kosik
Journal:  Cancer Res       Date:  2005-07-15       Impact factor: 12.701

10.  Type I interferons keep activated T cells alive.

Authors:  P Marrack; J Kappler; T Mitchell
Journal:  J Exp Med       Date:  1999-02-01       Impact factor: 14.307

View more
  61 in total

Review 1.  Biological therapy and the immune system in patients with chronic myeloid leukemia.

Authors:  Peter Rohon
Journal:  Int J Hematol       Date:  2012-06-04       Impact factor: 2.490

2.  Latency type-dependent modulation of Epstein-Barr virus-encoded latent membrane protein 1 expression by type I interferons in B cells.

Authors:  Daniel Salamon; Monika Adori; Dorina Ujvari; Liang Wu; Lorand L Kis; Harsha S Madapura; Noemi Nagy; George Klein; Eva Klein
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

3.  HIPK2 is necessary for type I interferon-mediated antiviral immunity.

Authors:  Lili Cao; Guang Yang; Shandian Gao; Chunxia Jing; Ruth R Montgomery; Yuxin Yin; Penghua Wang; Erol Fikrig; Fuping You
Journal:  Sci Signal       Date:  2019-03-19       Impact factor: 8.192

4.  IQGAP2 is a novel interferon-alpha antiviral effector gene acting non-conventionally through the NF-κB pathway.

Authors:  Cynthia Brisac; Shadi Salloum; Victor Yang; Esperance A K Schaefer; Jacinta A Holmes; Stephane Chevaliez; Jian Hong; Charlie Carlton-Smith; Nadia Alatrakchi; Annie Kruger; Wenyu Lin; Raymond T Chung
Journal:  J Hepatol       Date:  2016-07-09       Impact factor: 25.083

5.  Heat shock protein 27 mediated signaling in viral infection.

Authors:  Jaya Rajaiya; Mohammad A Yousuf; Gurdeep Singh; Heather Stanish; James Chodosh
Journal:  Biochemistry       Date:  2012-07-05       Impact factor: 3.162

Review 6.  Ubiquitination-mediated regulation of interferon responses.

Authors:  Serge Y Fuchs
Journal:  Growth Factors       Date:  2012-03-07       Impact factor: 2.511

7.  Repression of eEF2K transcription by NF-κB tunes translation elongation to inflammation and dsDNA-sensing.

Authors:  Christopher Bianco; Letitia Thompson; Ian Mohr
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-21       Impact factor: 11.205

Review 8.  Genetic variants at the IFNL3 locus and their association with hepatitis C virus infections reveal novel insights into host-virus interactions.

Authors:  Sreedhar Chinnaswamy
Journal:  J Interferon Cytokine Res       Date:  2014-02-20       Impact factor: 2.607

9.  Contribution of double-stranded RNA and CPSF30 binding domains of influenza virus NS1 to the inhibition of type I interferon production and activation of human dendritic cells.

Authors:  Irene Ramos; Elena Carnero; Dabeiba Bernal-Rubio; Christopher W Seibert; Liset Westera; Adolfo García-Sastre; Ana Fernandez-Sesma
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

10.  Bortezomib sensitizes human glioblastoma cells to induction of apoptosis by type I interferons through NOXA expression and Mcl-1 cleavage.

Authors:  Ruishan Wang; Andrew M Davidoff; Lawrence M Pfeffer
Journal:  Biochem Biophys Res Commun       Date:  2016-07-20       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.